Related Experiment Video

Updated: Sep 30, 2026

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
12:03

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Published on: June 7, 2016

[Gene expression of Ang II receptors in myocardium in congestive heart failure]

Lixia Yang1, Feng Qi, Yongjian Yang

  • 1Department of Cardiology of Kunming General Hospital, Chengdu Military Area, Kunming 650032, China.

Zhonghua Nei Ke Za Zhi
|July 23, 2002
PubMed

Insights

In congestive heart failure (CHF), AT(1)-receptor expression initially rises then falls, while AT(2)-receptor expression remains unchanged, suggesting a shift in receptor dominance and potential protective mechanisms.

Area of Science:

  • Cardiovascular Research
  • Molecular Cardiology
  • Renal Physiology

Context:

  • Congestive heart failure (CHF) involves complex cardiac remodeling.
  • The renin-angiotensin system, including AT(1) and AT(2) receptors, plays a critical role in cardiovascular regulation.
  • Understanding receptor expression changes is vital for managing heart failure.

Purpose:

  • To investigate the relationship between myocardial AT(1)- and AT(2)-receptor expression.
  • To correlate receptor expression with myocardial remodeling and cardiac function in CHF patients.
  • To elucidate the role of these receptors in the pathophysiology of valvular heart disease-induced CHF.

Summary:

  • Myocardial remodeling was observed in CHF patients.
  • AT(1)-receptor mRNA expression increased in mild CHF but decreased in moderate to severe CHF.
  • AT(2)-receptor mRNA expression showed no significant changes across patient groups.

Impact:

  • AT(1)-receptor up-regulation in early CHF may mediate cardiomyocyte hypertrophy.
  • Down-regulation of AT(1)-receptors and potential AT(2)-receptor dominance in advanced CHF might represent a protective response.
  • AT(2)-receptor activation could potentially induce cardiomyocyte apoptosis, contributing to cardiac dysfunction.
Abstract

More Related Videos

Ascending Aortic Constriction in Rats for Creation of Pressure Overload Cardiac Hypertrophy Model10:18

Ascending Aortic Constriction in Rats for Creation of Pressure Overload Cardiac Hypertrophy Model

Published on: June 29, 2014

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...